Royal Jelly Capsules 1650
Country: Australia
Language: English
Source: Department of Health (Therapeutic Goods Administration)
Public Assessment Report
(PAR)
24-11-2017
Some documents for this product are not currently available, you can send a request to our customer service and we will notify you as soon as we are able to obtain them.
Send request.
Send request.
Active ingredient:
Royal jelly lyophilised, Quantity: 550 mg (Equivalent: 10-hydroxy-2-decenoic acid, Qty 33 mg; Equivalent: Royal Jelly fresh, Qty 1.65 g)
Available from:
Chalmers Dale & Co Pty Ltd
INN (International Name):
Royal Jelly fresh
Pharmaceutical form:
Capsule, hard
Composition:
Excipient Ingredients: hypromellose; purified talc; calcium hydrogen phosphate dihydrate; colloidal anhydrous silica; microcrystalline cellulose; purified water; sodium starch glycollate type A
Administration route:
Oral
Therapeutic indications:
Antioxidant/Reduce free radicals formed in the body ; Maintain/support general health and wellbeing
Product summary:
Visual Identification: ;
Authorization status:
Licence status A
Authorization date:
2016-03-03
